Earnings Call · Q2 FY2023·2023-08-09

Q2 23EPS +25.00%·Rev n/aQ1 23EPS +50.00%·Rev n/aQ4 22EPS +20.00%·Rev n/aQ3 22EPS -42.86%·Rev n/a⚠ consensus missing

Organogenesis Holdings Inc. ORGO

Gary Gillheeney — Chief Executive Officer

David Francisco — Chief Financial Officer

−18.9%1d on move date−18.9% vs SPY3d−20.4%5d−23.0%

Research tier

Behavioral profile computed for 2 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more ORGO calls or request research access.

More ORGO calls Browse calls Request research access